Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 159 Records) |
| Query Trace: Lung Neoplasms and ERBB2[original query] |
|---|
| Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions. Frontiers in oncology 2022 12 952572. Qiu Yuan, Liu Liping, Yang Haihong, Chen Hanzhang, Deng Qiuhua, Xiao Dakai, Lin Yongping, Zhu Changbin, Li Weiwei, Shao Di, Jiang Wenxi, Wu Kui, He Jianxi |
| A case of multiple primary lung adenocarcinoma with a CD74-NRG1 fusion protein and HER2 mutation benefit from combined target therapy. Thoracic cancer 2022 9 13 (21): 3063-3067. Chen Kai, Li Wen, Xi Xiaoming, Zhong J |
| Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy. Therapeutic advances in medical oncology 2022 12 14 17588359221141761. Lee Jii Bum, Park Hyung Soon, Choi Su Jin, Heo Seong Gu, An Ho Jung, Kim Hye Ryun, Hong Min Hee, Lim Sun Min, Chang Kyle, Quinn Katie, Odegaard Justin, Shim Byoung Yong, Cho Byoung Ch |
| Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component. Frontiers in oncology 2022 12 12 989349. Li Peng, Liu Lu, Wang Dong, Yang Ronghua, Xuan Yunpeng, Han Yudong, Wang Jinglong, Guo Lijie, Zhang Liwen, Zhang Shanshan, Wang Yongj |
| The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study. JTO clinical and research reports 2022 11 3 (12): 100427. Benjamin David J, Chen Shuai, Eldredge Joanna B, Schokrpur Shiruyeh, Li Debory, Quan Zhikuan, Chan Jason W, Cummings Amy L, Daly Megan E, Goldman Jonathan W, Gubens Matthew A, Harris Jeremy P, Onaitis Mark W, Zhu Viola W, Patel Sandip P, Kelly Kar |
| Genomic landscape of lung cancer in the young. Frontiers in oncology 2022 12 910117. Ruiz Rossana, Galvez-Nino Marco, Roque Katia, Montes Jaime, Nuñez Maria, Raez Luis, Sánchez-Gambetta Sergio, Jaúregui Sandra, Viale Sandra, Smith Edward S, Pinto Joseph A, Mas Lu |
| Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer. PloS one 2022 17 (10): e0276161. Chow Yock Ping, Zainul Abidin Norziha, Kow Ken Siong, Tho Lye Mun, Wong Chieh L |
| ERBB2 exon 20 insertions are rare in Brazilian non-small cell lung cancer. Thoracic cancer 2022 Oct . de Oliveira Cavagna Rodrigo, Zaniolo Beatriz Garbe, de Paula Flávia Escremim, Berardinelli Gustavo Noriz, Santana Iara, da Silva Eduardo Caetano Albino, Dias Josiane Mourão, Jacinto Alexandre Arthur, da Nóbrega Oliveira Rachid Eduardo Noleto, de Marchi Pedro, Leal Letícia Ferro, Reis Rui Manu |
| Genomic landscape of lung adenocarcinomas in different races. Frontiers in oncology 2022 12 946625. Shi Huashan, Seegobin Karan, Heng Fei, Zhou Kexun, Chen Ruqin, Qin Hong, Manochakian Rami, Zhao Yujie, Lou Yany |
| Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance. Japanese journal of clinical oncology 2023 9 . Jie Zheng, Yuanyao Dou, Daijuan Huang, Yubo Wang, Rui Han, Chen Hu, Mengxiao Zhu, Conghua Lu, Caiyu Lin, Di Wu, Yihui Liu, Huan Tang, Tingting He, Weilin Jiang, Yong |
| Compromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data. JCO oncology practice 2023 8 OP2200611. Jeffrey A Scott, Jochen Lennerz, Melissa Lynne Johnson, Lucio N Gordan, Robert H Dumanois, Luca Quagliata, Lauren L Ritterhouse, Federico Cappuzzo, Brandon Wang, Mei Xue, Anupama Vasudevan, Prateesh Varughese, Varun Vaidya, Mike Gart, Natalie Dorrow, Hinco J Gierman, Rushir J Chok |
| EGFR co-mutation is associated with the risk of recurrence in invasive lung adenocarcinoma with the micropapillary component. Asian journal of surgery 2023 8 . Haixin Kang, Haiyan Lv, Tao-Hsin Tung, Dehua Ma, Zheng Wang, Juping Du, Kai Zhou, Juan Pan, Yanjie Zhang, Shuotao Peng, Zhaonan Yu, Bo Shen, Minhua |
| Exploration of HER2 (ERBB2) immunohistochemistry in non-small cell lung cancer: correlation with ERBB2 mutational status: experimental research. Annals of medicine and surgery (2012) 2023 6 85 (6): 2640-2646. Anthony B Cardillo, Sierra Kovar, Nitin Roper, David G Hicks, Moises J Vel |
| Pertuzumab Plus Trastuzumab in Patients With Lung Cancer With ERBB2 Mutation or Amplification: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 2023 6 7 e2300041. Apar K Ganti, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Elie G Dib, Herbert L Duvivier, Eugene R Ahn, Deepti Behl, Hossein Borghaei, Ani S Balmanoukian, Anu Gaba, Rui Li, Kwabena Osei-Boateng, Ramya Thota, Gina N Grantham, Abigail Gregory, Susan Halabi, Richard L Schils |
| Genomic characteristics and prognosis of lung cancer patients with MSI-H: A cohort study. Lung cancer (Amsterdam, Netherlands) 2023 5 181 107255. Jie Tian, Hongdan Wang, Conghua Lu, Lan Liu, Xianquan Zhang, Yunbo Xie, Rutian Li, Xin Lv, Dan Fu, Ling Zhang, Xisheng Fang, Xuming Wang, Jing Hu, Xinyi Liu, Xiaochun Huang, Qian Zhao, Nuo Luo, Huan Tang, Zhaoyang Zhong, Yong He, Li |
| The Unique Genetic Mutation Characteristics Based on Large Panel Next-Generation Sequencing (NGS) Detection in Multiple Primary Lung Cancers (MPLC) Patients. Discovery medicine 2023 5 35 (175): 131-143. Zhu Liang, Guoxiong Zeng, Wang Wan, Biao Deng, Chunyuan Chen, Fasheng Li, Guanzhou Lin, Yuying Lin, Haitao Lin, Guixi Mo, Huilai Mi |
| Comprehensive molecular characterizations of stage I-III lung adenocarcinoma with tumor spread through air spaces. Frontiers in genetics 2023 2 14 1101443. Ye Ronghao, Yu Yongfeng, Zhao Ruiying, Han Yuchen, Lu Sh |
| Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective. Pathology, research and practice 2023 12 253 155013. Aditi Aggarwal, Shivani Sharma, Zoya Brar, Vipin Kumar, Akash Kumar, Rahul Katara, Sambit K Mohan |
| Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion. Current oncology (Toronto, Ont.) 2023 11 30 (11): 9929-9939. Yue Zheng, Yang Fu, Yueyun Chen, Qing Li, Ting Liu, Zhenyu Di |
| Investigation of the prevalence and clinical implications of ERBB2 exon 16 skipping mutations in Chinese pan-cancer patients. Frontiers in oncology 2023 1 12 1064598. Shang Yanhong, Mo Jianming, Huo Ran, Li Xiaofang, Fang Guotao, Wei Zichun, Gu Guomin, Zhu Xiaodan, Zhang Chan, Liu Chunling, Yan Do |
| Registry of Genetic Alterations of Taiwan Non-Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521. JCO global oncology 2024 9 10 e2400125. Bin-Chi Liao, Nai-Jung Chiang, Gee-Chen Chang, Wu-Chou Su, Yung-Hung Luo, Inn-Wen Chong, Tsung-Ying Yang, Chun-Liang Lai, Te-Chun Hsia, Ching-Liang Ho, Kang-Yun Lee, Chin-Fu Hsiao, Fan-Chen Ku, Wei-Tse Fang, James Chih-Hsin Ya |
| Clinical Utility of Circulating Tumor DNA for Detecting Lung Cancer Mutations by Targeted Next-Generation Sequencing With Insufficient Tumor Samples. Journal of clinical laboratory analysis 2024 9 e25099. Yi Sun, Xu Zhang, Xinhua Yang, Jiangjun |
| Clinical and Genetic Characteristics of Early-onset Lung Adenocarcinoma in a Large Chinese Cohort. The Annals of thoracic surgery 2024 9 . Shouzhi Xie, Qikang Hu, Zeyu Wu, Bin Wang, Yu He, Qi Huang, Zhe Zhang, Zhi Yang, Shengrong Wu, Weiyu Yang, Xinhang Hu, Xuyang Yi, Hao He, Cheng Wang, Fenglei Yu, Muyun Pe |
| Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non-Small Cell Lung Cancer. JCO precision oncology 2024 8 8 e2300520. Huaying Wang, Lie Lin, Chuqiao Liang, Jiaohui Pang, Jiani C Yin, Junli Zhang, Yang Shao, Chengming Sun, Renhua G |
| Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers. BMC cancer 2024 8 24 (1): 951. Javiera Garrido, Yanara Bernal, Evelin González, Alejandro Blanco, Gonzalo Sepúlveda-Hermosilla, Matías Freire, Karen Oróstica, Solange Rivas, Katherine Marcelain, Gareth Owen, Carolina Ibañez, Alejandro Corvalan, Marcelo Garrido, Rodrigo Assar, Rodrigo Lizana, Javier Cáceres-Molina, Diego Ampuero, Liliana Ramos, Paola Pérez, Osvaldo Aren, Sara Chernilo, Cristina Fernández, María Loreto Spencer, Jacqueline Flores Aguila, Giuliano Bernal Dossetto, Mónica Ahumada Olea, Germán Rasse, Carolina Sánchez, Maria Galli de Amorim, Thais F Bartelli, Diana Noronha Nunes, Emmanuel Dias-Neto, Helano C Freitas, Ricardo Armis |
| Mutations Associated With High-Grade irAEs in NSCLC Patients Receiving Immunotherapies. Clinical lung cancer 2024 8 . Margaret R Smith, Yuezhu Wang, Caroline B Dixon, Ralph D'Agostino, Yin Liu, Jimmy Ruiz, George Oliver, Lance D Miller, Umit Topaloglu, Michael D Chan, Michael Farris, Jing Su, Kathryn F Mileham, Wencheng Li, Jason M Grayson, Thomas Lycan, Fei Xi |
| Sex- and Age-Associated Differences in Genomic Alterations among Patients with Advanced Non-Small Cell Lung Cancer (NSCLC). Cancers 2024 7 16 (13): . ErinMarie O Kimbrough, Julian A Marin-Acevedo, Leylah M Drusbosky, Ariana Mooradian, Yujie Zhao, Rami Manochakian, Yanyan L |
| Molecular profile of driver genes in lung adenocarcinomas of Brazilian patients who have never smoked: implications for targeted therapies. The oncologist 2024 6 . Rodrigo de Oliveira Cavagna, Flávia Escremim de Paula, Gustavo Noriz Berardinelli, Murilo Bonatelli, Iara Santana, Eduardo Caetano Albino da Silva, Gustavo Ramos Teixeira, Beatriz Garbe Zaniolo, Josiane Mourão Dias, Flávio Augusto Ferreira da Silva, Carlos Eduardo Baston Silva, Marcela Gondim Borges Guimarães, Camila Pinto Barone, Alexandre Arthur Jacinto, Rachid Eduardo Noleto da Nóbrega Oliveira, José Elias Miziara, Pedro De Marchi, Miguel A Molina-Vila, Letícia Ferro Leal, Rui Manuel Re |
| PD-L1 expression in patients with non-small-cell lung cancer is associated with sex and genetic alterations: A retrospective study within the Caucasian population. Thoracic cancer 2024 6 . P Sarova, B Mosleh, S Zehetmayer, F Oberndorfer, J Widder, H Prosch, C Aigner, M Idzko, M A Hoda, D Gompelma |
| Molecular landscape of ERBB2 alterations in 3000 advanced NSCLC patients. NPJ precision oncology 2024 10 8 (1): 217. Lingzhi Hong, Sonia Patel, Leylah M Drusbosky, Yuanyuan Xiong, Rongrong Chen, Ruixuan Geng, Simon Heeke, Monique Nilsson, Jia Wu, John V Heymach, Yingyi Wang, Jianjun Zhang, Xiuning |
- Page last reviewed:Feb 1, 2024
- Content source: